Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 25(11)2024 May 28.
Artigo em Inglês | MEDLINE | ID: mdl-38892076

RESUMO

Epidural and subdural hematomas are commonly associated with traumatic brain injury. While surgical removal is the primary intervention for these hematomas, it is also critical to prevent and reduce complications such as post-traumatic epilepsy, which may result from inflammatory responses in the injured brain areas. In the present study, we observed that high mobility group box-1 (HMGB1) decreased in the injured brain area beneath the epidural hematoma (EDH) in rats, concurrent with elevated plasma levels of HMGB1. Anti-HMGB1 monoclonal antibody therapy strongly inhibited both HMGB1 release and the subsequent increase in plasma levels. Moreover, this treatment suppressed the up-regulation of inflammatory cytokines and related molecules such as interleukin-1-beta (IL-1ß), tumor necrosis factor-alpha (TNF-α), and inducible nitric oxide synthase (iNOS) in the injured areas. Our in vitro experiments using SH-SY5Y demonstrated that hematoma components-thrombin, heme, and ferrous ion- prompted HMGB1 translocation from the nuclei to the cytoplasm, a process inhibited by the addition of the anti-HMGB1 mAb. These findings suggest that anti-HMGB1 mAb treatment not only inhibits HMGB1 translocation but also curtails inflammation in injured areas, thereby protecting the neural tissue. Thus, anti-HMGB1 mAb therapy could serve as a complementary therapy for an EDH before/after surgery.


Assuntos
Anticorpos Monoclonais , Proteína HMGB1 , Hematoma Epidural Craniano , Proteína HMGB1/metabolismo , Animais , Ratos , Anticorpos Monoclonais/farmacologia , Anticorpos Monoclonais/uso terapêutico , Hematoma Epidural Craniano/tratamento farmacológico , Masculino , Humanos , Ratos Sprague-Dawley , Interleucina-1beta/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Citocinas/metabolismo , Óxido Nítrico Sintase Tipo II/metabolismo , Linhagem Celular Tumoral
2.
J Spinal Disord Tech ; 28(9): 313-8, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26484502

RESUMO

Postoperative epidural hematomas are rare complications following lumbar spine surgery, but if they are not quickly identified and treated they can lead to permanent neurological deficits. Epidural hematomas occur in approximately 0.10%-0.24% of all spine surgeries, and despite the fact that multiple large studies have been performed attempting to identify risk factors for this complication, there is still significant debate about the effect of subfascial drains, postoperative anticoagulation, and antiplatelet medication on the incidence of postoperative hematoma. The purpose of this manuscript is to review the epidemiology, etiology, diagnosis, and treatment of patients who develop a postoperative lumbar epidural hematoma.


Assuntos
Hematoma Epidural Craniano/etiologia , Vértebras Lombares/cirurgia , Complicações Pós-Operatórias/etiologia , Anticoagulantes/uso terapêutico , Drenagem , Hematoma Epidural Craniano/diagnóstico , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/epidemiologia , Humanos , Imageamento por Ressonância Magnética , Inibidores da Agregação Plaquetária/uso terapêutico , Período Pós-Operatório , Fatores de Risco
3.
J Clin Neurosci ; 80: 264-266, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33099358

RESUMO

BACKGROUND: Pancytopenia has only rarely been reported with Levetiracetam use. It is a potentially life threatening adverse effect that requires cessation of therapy. CASE DESCRIPTION: We describe a case of an otherwise well thirty-two-year-old man who underwent an emergent craniotomy for evacuation of a traumatic extra-dural haematoma. Post-operatively, he developed pancytopenia which corrected with cessation of levetiracetam. CONCLUSION: This report aims to increase awareness of this rare side effect and reiterates the judicious use of prophylactic levetiracetam in brain trauma.


Assuntos
Anticonvulsivantes/efeitos adversos , Lesões Encefálicas Traumáticas/tratamento farmacológico , Hematoma Epidural Craniano/tratamento farmacológico , Levetiracetam/efeitos adversos , Pancitopenia/induzido quimicamente , Profilaxia Pós-Exposição , Adulto , Lesões Encefálicas Traumáticas/diagnóstico por imagem , Lesões Encefálicas Traumáticas/cirurgia , Craniotomia/métodos , Hematoma Epidural Craniano/diagnóstico por imagem , Hematoma Epidural Craniano/cirurgia , Humanos , Masculino , Pancitopenia/diagnóstico por imagem , Profilaxia Pós-Exposição/tendências
4.
J Trauma ; 66(3): 942-50, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19276776

RESUMO

Trauma and emergency department clinicians encounter a growing number of patients admitted with traumatic head injury on prehospital antithrombotic therapies. These patients appear to be at increased risk of developing life-threatening intracranial hemorrhage. It is imperative that trauma clinicians understand the mechanism and duration of commonly prescribed outpatient antithrombotics in order to appropriately assess and treat patients who develop intracranial hemorrhage. This review summarizes current literature on the morbidity and mortality associated with premorbid non-steroidal anti-inflammatory drugs, aspirin, clopidogrel, warfarin, and heparinoids in the setting of traumatic head injury, and also examines the current strategies for reversal of these therapies.


Assuntos
Anticoagulantes/efeitos adversos , Lesões Encefálicas/complicações , Hemorragia Cerebral Traumática/induzido quimicamente , Serviços Médicos de Emergência , Hemostáticos/uso terapêutico , Inibidores da Agregação Plaquetária/efeitos adversos , Idoso , Anticoagulantes/administração & dosagem , Lesões Encefálicas/tratamento farmacológico , Lesões Encefálicas/mortalidade , Hemorragia Cerebral Traumática/tratamento farmacológico , Hemorragia Cerebral Traumática/mortalidade , Terapia Combinada , Cuidados Críticos , Desamino Arginina Vasopressina/administração & dosagem , Fator VIIa/administração & dosagem , Hematoma Epidural Craniano/induzido quimicamente , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/mortalidade , Hematoma Subdural/induzido quimicamente , Hematoma Subdural/tratamento farmacológico , Hematoma Subdural/mortalidade , Mortalidade Hospitalar , Humanos , Pessoa de Meia-Idade , Plasma , Inibidores da Agregação Plaquetária/administração & dosagem , Transfusão de Plaquetas , Protaminas/administração & dosagem , Proteínas Recombinantes/administração & dosagem , Fatores de Risco , Vitamina K 1/administração & dosagem
5.
Rev Recent Clin Trials ; 14(4): 286-291, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31218964

RESUMO

BACKGROUND: Recovery of patients with traumatic brain injury largely depends on the reduction in secondary brain damage. The present study aims at investigating the effect of Tranexamic Acid (TXA) administration within the first hours of brain trauma in the emergency department (ED). METHODS: This randomized, double-blind, placebo-controlled clinical trial was carried out in patients with subdural and epidural hemorrhage. Patients with any type of bleeding were assigned into two groups of TXA and 0.9% normal saline as placebo. The rate of intracranial hemorrhage after surgery was assessed by CT-scan and amount of hemoglobin (Hb) was measured immediately before surgery and after 6 hours of surgery. RESULTS: A total of 80 participants were randomly assigned into four groups of 20 people. There was a significant difference in the mean of intraoperative bleeding during surgery in patients receiving TXA and placebo in both SDH (Subdural hematoma) and EDH (Epidural Hemorrhage) groups (P= 0.012). The Hb drop amount had no significant difference with placebo (P< 0.0001). No complications were observed in any of the intervention and control groups during the study as well. CONCLUSION: The use of TXA may reduce bleeding, however, based on the results of this study, such effect was not statistically significant in controlling the epidural and subdural hemorrhage, but clinical trials with a higher sample size are suggested for further investigation in this regard.


Assuntos
Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Subdural/tratamento farmacológico , Ácido Tranexâmico/administração & dosagem , Adulto , Antifibrinolíticos/administração & dosagem , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Seguimentos , Hematoma Epidural Craniano/diagnóstico , Hematoma Subdural/diagnóstico , Humanos , Infusões Intravenosas , Masculino , Estudos Retrospectivos , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Adulto Jovem
6.
Crit Care ; 12(4): 172, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18771586

RESUMO

Femoral access for renal replacement therapy appears to have a similar infection rate to jugular access. High-intensity renal support does not seem to improve mortality or length of hospital stay. Acute kidney injury as defined by Acute Kidney Injury Network predicts increased hospital mortality. Recombinant factor VIIa reduces growth of volume of intracerebral haematoma but does not affect clinical outcome. Sustained released metoprolol reduces perioperative cardiac events in non-cardiac surgery but leads to more deaths and strokes. Steroids are probably not beneficial in either children with non-Haemophilus influenzae type b bacterial meningitis, or in prophylaxis of acute respiratory distress syndrome (ARDS), but could be beneficial in the treatment of ARDS.


Assuntos
Antagonistas Adrenérgicos beta/administração & dosagem , Hematoma Epidural Craniano/tratamento farmacológico , Publicações/tendências , Terapia de Substituição Renal/métodos , Esteroides/administração & dosagem , Ensaios Clínicos como Assunto/tendências , Hematoma Epidural Craniano/patologia , Humanos
7.
Acta Neurochir (Wien) ; 150(4): 359-66; discussion 366, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18288440

RESUMO

BACKGROUND: As an effective treatment for post-craniotomy epidural haematomas (EDHs), a novel method of urokinase instillation using a closed suction drain is presented and the procedure feasibility and outcomes assessed. METHOD: A closed system, comprising a closed suction drain with a three-spring 200 mL evacuator, fluid bag with urokinase, and syringe, was constructed to instill urokinase and evacuate a postoperative EDH. Nine patients with a symptomatic, localised EDH under a bone flap after a craniotomy underwent successive urokinase instillation following the proposed protocol. Measurement of the EDH volume and clinical evaluation were performed. FINDINGS: An improvement of computerised tomography findings and clinical state after urokinase instillation was observed in all patients. Six urokinase instillations lasting 12 h in 6 patients with an EDH (18.2 +/- 2.4 mL) and 12 urokinase instillations lasting 24 h in the other 3 patients with an EDH (33.0 +/- 7.9 mL) succeeded in achieving a minimal residual EDH (6.1 +/- 2.8 mL). The EDH volume decreased at a rate of 13.0 +/- 2.3 mL/12 h. The GCS scores increased immediately after thrombolytic evacuation of the EDHs in 6 out of the 9 patients. For the other three patients who did not show a change of GCS score, the severe headaches were improved. All the patients were successfully treated using the proposed technique with no procedural complications such as haemorrhage or infection in the operative wound. CONCLUSIONS: This pilot study demonstrated that thrombolytic evacuation of a post-craniotomy EDH using a closed suction drain is feasible without complications and may be associated with better outcomes.


Assuntos
Craniotomia , Fibrinolíticos/administração & dosagem , Hematoma Epidural Craniano/tratamento farmacológico , Complicações Pós-Operatórias/tratamento farmacológico , Sucção/instrumentação , Terapia Trombolítica/instrumentação , Ativador de Plasminogênio Tipo Uroquinase/administração & dosagem , Idoso , Esquema de Medicação , Feminino , Escala de Coma de Glasgow , Hematoma Epidural Craniano/diagnóstico por imagem , Humanos , Processamento de Imagem Assistida por Computador , Injeções Epidurais , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Complicações Pós-Operatórias/diagnóstico por imagem , Estudos Retrospectivos , Tomografia Computadorizada por Raios X , Resultado do Tratamento
8.
J Neurol Surg A Cent Eur Neurosurg ; 79(1): 39-44, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28962067

RESUMO

BACKGROUND AND STUDY AIMS: Cranioplasty is a cosmetic procedure utilized to reconstruct cranial defects in patients following decompressive craniectomy. Epidural hematomas are a common complication of cranioplasty and often require surgical drainage. However, repeated surgery compromises patient safety and delays recovery. MATERIAL AND METHODS: We investigated the development of epidural hematomas among 131 patients who underwent cranioplasty. Then we explored the efficacy of urokinase (UK) injection for the noninvasive treatment of epidural hematomas. We observed that 15 patients presented with epidural hematoma following cranioplasty. UK (30,000 IU/3 mL) was injected into the hematoma cavity twice every 12 hours in the first postoperative day. Next we closed the subgaleal drain for 1.5 hours and connected it with a negative-pressure ball on full vacuum to allow drainage. Binary logistic regression analysis was used to evaluate the risk factors associated with the development of epidural hematomas. RESULTS: Our findings demonstrated that a sunken skin flap was a risk factor for epidural hematoma formation (p = 0.006). The decrease in epidural hematoma volume was 35.27 ± 7.27 mL in the first 12 hours on postoperative day 1 after UK treatment. All treated patients whose Glasgow Coma Scale score did not significantly change despite the epidural hematoma had an uneventful recovery without additional complications and were discharged from the hospital, except for one patient. CONCLUSION: Fibrinolytic therapy can be considered an optional treatment for postoperative epidural hematoma associated with cranioplasty, especially in patients who refused further operative treatment or who are not optimal candidates for a second surgery.


Assuntos
Craniectomia Descompressiva/efeitos adversos , Fibrinolíticos/uso terapêutico , Hematoma Epidural Craniano/tratamento farmacológico , Procedimentos de Cirurgia Plástica/efeitos adversos , Terapia Trombolítica , Ativador de Plasminogênio Tipo Uroquinase/uso terapêutico , Adulto , Feminino , Escala de Coma de Glasgow , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/etiologia , Reoperação , Estudos Retrospectivos , Crânio/cirurgia , Resultado do Tratamento
9.
World Neurosurg ; 110: 206-209, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29158097

RESUMO

BACKGROUND: Hematoma evacuation is regular treatment for acute traumatic epidural hematoma (ATEDH) patients meeting with surgery indications. However, it is an invasive approach performed under general anesthesia. Here, a novel minimally invasive method of endovascular embolization with subsequent drainage surgery and use of urokinase was established to treat ATEDH under local anesthesia. METHODS: A novel minimally invasive method of endovascular embolization with subsequent drainage surgery and use of urokinase was established to treat ATEDH under local anesthesia. Firstly, 23 ATEDH patients with hematomas in the temporal area underwent digital subtraction angiography detecting the bleeding point. Next, embolization was performed. After embolization, drainage surgery was taken and urokinase was injected into the hematoma cyst by drainage tube to lyse hematoma twice per day. RESULTS: The results showed that the middle meningeal artery was the bleeding source. Embolization immediately ceased bleeding. Most clots were resolved and drained after treatment. No recurrence of hematoma or infection was observed. CONCLUSION: The findings suggest that the combined treatments can be an alternative minimally invasive option for ATEDHs, especially for elderly patients or those contraindicated for general anesthesia.


Assuntos
Drenagem/métodos , Embolização Terapêutica/métodos , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/cirurgia , Ativador de Plasminogênio Tipo Uroquinase/uso terapêutico , Adolescente , Adulto , Angiografia Digital , Feminino , Hematoma Epidural Craniano/diagnóstico por imagem , Humanos , Masculino , Artérias Meníngeas/diagnóstico por imagem , Artérias Meníngeas/cirurgia , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Adulto Jovem
10.
Stroke ; 38(6): 1855-9, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17478737

RESUMO

BACKGROUND AND PURPOSE: Plasma levels of cellular fibronectin (c-Fn) > or =3.6 microg/mL and of matrix metalloproteinase-9 (MMP-9) > or =140 ng/mL have been associated with parenchymal hematoma (PH) after treatment with tissue-type plasminogen activator (t-PA) in patients with acute ischemic stroke. In this prospective study, we sought to validate the predictive capacity of the preestablished cutoff values of these biomarkers for PH in a larger series of patients. METHODS: We studied 134 patients treated with t-PA within 3 hours from symptom onset according to the SITS-MOST criteria (median time to infusion, 152 minutes; median National Institutes of Health Stroke Scale score, 14) in 4 university hospitals. Hemorrhagic transformation was classified according to the European-Australasian Acute Stroke Study II definitions on computed tomography scans performed 24 to 36 hours after treatment. Relevant hemorrhagic transformation was defined as hemorrhagic infarction type 2 or any PH. Serum c-Fn and MMP-9 levels were determined by an ELISA om blood samples obtained before treatment. RESULTS: Cranial computed tomography showed hemorrhagic transformation in 27 patients (20%), hemorrhagic infarction in 15 (type 2 in 8 patients), and PH in 12 patients (symptomatic in 4). Serum c-Fn and MMP-9 concentrations at baseline were significantly higher in patients with relevant hemorrhagic transformation and PH than in those without (all P<0.001). The sensitivity, specificity, and positive and negative predictive values for PH by c-Fn levels > or =3.6 microg/mL were 100%, 60%, 20%, and 100%, respectively, whereas corresponding values were 92%, 74%, 26%, and 99% for MMP-9 levels > or =140 ng/mL. When both biomarkers were at levels above the cutoff points, specificity increased to 87% and the positive predictive value increased to 41%. CONCLUSIONS: This prospective study confirmed the high sensitivity and negative predictive value, with retained good specificity, of c-Fn and MMP-9 for the prediction of PH in patients treated with t-PA. Development of faster analytic methods will prove the applicability of these biomarkers in routine clinical practice.


Assuntos
Isquemia Encefálica/sangue , Fibronectinas/sangue , Hematoma Epidural Craniano/sangue , Metaloproteinase 9 da Matriz/sangue , Acidente Vascular Cerebral/sangue , Terapia Trombolítica , Idoso , Biomarcadores/sangue , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/epidemiologia , Feminino , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Prospectivos , Acidente Vascular Cerebral/tratamento farmacológico , Acidente Vascular Cerebral/epidemiologia , Terapia Trombolítica/efeitos adversos
11.
Can J Neurol Sci ; 34(3): 307-12, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17803027

RESUMO

OBJECTIVE: To determine: 1. the degrees of consensus and disagreement among Canadian critical care clinicians regarding the appropriateness (benefit exceeding risk) of common therapeutic manoeuvres in patients with severe closed head injury (CHI), and 2. the frequency with which clinicians employed these manoeuvres. METHODS: The study design was a systematic scenario-based survey of all neurosurgeons and critical care physicians treating patients with severe CHI in Canada. RESULTS: In the scenario of acute epidural hematoma with mass effect, respondents agreed very strongly that surgery was appropriate. Clinicians reported mannitol and hypertonic saline as appropriate. Beyond these two interventions, agreement was less strong, and the use of the extraventricular drain (EVD), phenytoin, cooling, hyperventilation, nimodipine, and jugular venous oximetry (JVO) were of uncertain appropriateness. Steroids were considered inappropriate. In a scenario of diffuse axonal injury (DAI), clinicians agreed strongly that fever reduction, early enteral feeding, intensive glucose control, and cerebral perfusion pressure (CPP)-directed management were appropriate. The use of mannitol, hypertonic saline, EVD, JVO, narcotics and propofol were also appropriate. Neuromuscular blockade, surgery, and hyperventilation were of uncertain appropriateness. The appropriateness ratings of the interventions considered in the scenario of an intracranial contusion mirrored the DAI scenario. In general, correlations between the reported appropriateness and frequency of use of each intervention were very high. An exception noted was the use of the JVO. The correlation between CPP-guided therapy and the use of the EVD was weak. CONCLUSIONS: This survey has described current practice with regard to treatment of patients with severe CHI. Areas of variation in perceived appropriateness were identified that may benefit from further evaluation. Suggested priorities for evaluation include the use of osmotic diuretics, anticonvulsants, and intracranial manometry.


Assuntos
Lesões Encefálicas/terapia , Cuidados Críticos/métodos , Traumatismos Cranianos Fechados/terapia , Pesquisas sobre Atenção à Saúde , Neurologia/métodos , Neurocirurgia/métodos , Padrões de Prática Médica/estatística & dados numéricos , Adulto , Anticonvulsivantes/uso terapêutico , Lesões Encefálicas/epidemiologia , Lesões Encefálicas/fisiopatologia , Canadá/epidemiologia , Cuidados Críticos/normas , Lesão Axonal Difusa/tratamento farmacológico , Lesão Axonal Difusa/fisiopatologia , Diuréticos Osmóticos/uso terapêutico , Feminino , Traumatismos Cranianos Fechados/epidemiologia , Traumatismos Cranianos Fechados/fisiopatologia , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/fisiopatologia , Hematoma Epidural Craniano/cirurgia , Humanos , Hipotermia Induzida/estatística & dados numéricos , Unidades de Terapia Intensiva , Hipertensão Intracraniana/diagnóstico , Hipertensão Intracraniana/prevenção & controle , Hipertensão Intracraniana/terapia , Masculino , Desnutrição/prevenção & controle , Desnutrição/terapia , Pessoa de Meia-Idade , Neurologia/normas , Neurocirurgia/normas , Medição de Risco
13.
J Clin Neurosci ; 26: 42-5, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26690758

RESUMO

Pre-treatment with antiplatelet agents is described to be a risk factor for mortality after spontaneous intracerebral hemorrhage (ICH). However, the impact of antithrombotic agents on mortality in patients who undergo hematoma evacuation compared to conservatively treated patients with ICH remains controversial. This analysis is based on a prospective registry for quality assurance in stroke care in the State of Hesse, Germany. Patients' data were collected between January 2008 and December 2012. Only patients with the diagnosis of spontaneous ICH were included (International Classification of Diseases 10th Revision codes I61.0-I61.9). Predictors of in-hospital mortality were determined by univariate analysis. Predictors with P<0.1 were included in a binary logistic regression model. The binary logistic regression model was adjusted for age, initial Glasgow Coma Score (GCS), the presence of intraventricular hemorrhage (IVH), and pre-ICH disability prior to ictus. In 8,421 patients with spontaneous ICH, pre-treatment with oral anticoagulants or antiplatelet agents was documented in 16.3% and 25.1%, respectively. Overall in-hospital mortality was 23.2%. In-hospital mortality was decreased in operatively treated patients compared to conservatively treated patients (11.6% versus 24.0%; P<0.001). Patients with antiplatelet pre-treatment had a significantly higher risk of death during the hospital stay after hematoma evacuation (odds ratio [OR]: 2.5; 95% confidence interval [CI]: 1.24-4.97; P=0.010) compared to patients without antiplatelet pre-treatment treatment (OR: 0.9; 95% CI: 0.79-1.09; P=0.376). In conclusion a higher rate of in-hospital mortality after pre-treatment with antiplatelet agents in combination with hematoma evacuation after spontaneous ICH was observed in the presented cohort.


Assuntos
Anticoagulantes/efeitos adversos , Fibrinolíticos/efeitos adversos , Hematoma Epidural Craniano/terapia , Inibidores da Agregação Plaquetária/efeitos adversos , Idoso , Idoso de 80 Anos ou mais , Anticoagulantes/uso terapêutico , Feminino , Fibrinolíticos/uso terapêutico , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/mortalidade , Hematoma Epidural Craniano/cirurgia , Mortalidade Hospitalar , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Inibidores da Agregação Plaquetária/uso terapêutico , Estudos Prospectivos , Sistema de Registros , Fatores de Risco , Acidente Vascular Cerebral/tratamento farmacológico
14.
World Neurosurg ; 93: 489.e17-20, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27368506

RESUMO

OBJECTIVE: To present, to our knowledge, the first case of a single bilateral extradural hematoma due to superior sagittal sinus detachment that was treated conservatively with an excellent outcome. METHODS: Bilateral extradural hematomas are a rare condition, accounting for only 2%-5% of all extradural hematomas. They can be either 2 distinct hematomas on either side or 1 single bilateral hematoma mostly due to sagittal sinus injury, with the latter being the most rare owing to the firm attachment of the sinus to its subperiosteal loggia. These hematomas usually require immediate surgical evacuation, as patients present with decreased level of consciousness, and have good postoperative outcomes. We present a bilateral extradural hematoma due to superior sagittal sinus injury, which was treated conservatively. RESULTS: The patient had an excellent recovery, with no residual neurological deficits and a Glasgow outcome scale of 5 on discharge. CONCLUSION: Bilateral extradural hematomas due to superior sagittal sinus injury almost always require surgical intervention. We present a patient who was treated conservatively with an excellent outcome and we also perform a review of the current literature.


Assuntos
Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/etiologia , Fármacos Neuroprotetores/administração & dosagem , Lobo Parietal/lesões , Seio Sagital Superior/efeitos dos fármacos , Seio Sagital Superior/lesões , Adulto , Anticoagulantes/administração & dosagem , Anticonvulsivantes/administração & dosagem , Lesões Encefálicas/complicações , Quimioterapia Combinada/métodos , Heparina de Baixo Peso Molecular/administração & dosagem , Humanos , Levetiracetam , Masculino , Manitol/administração & dosagem , Neuroimagem/métodos , Piracetam/administração & dosagem , Piracetam/análogos & derivados , Resultado do Tratamento
15.
Neurology ; 37(8): 1351-6, 1987 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-3614655

RESUMO

Ten patients with a nontraumatic spinal extramedullary hematoma are reported, nine of the hematomas localized in the epidural space. Seven of the patients were taking anticoagulant drugs and five showed signs of liver disease, mostly due to alcoholism. The invariable first symptom was an intense local pain in the spine, followed in all but one case by radicular irradiation and in all by bladder disturbances and sensory and motor deficits of the spinal cord or cauda equina. All the patients had myelography to verify the spinal mass and were operated on as fast as possible. The outcome depended mainly on the preoperative neurologic status. If there was only an incomplete sensory and motor lesion before the operation, the patients recovered fairly well or completely. The patients who did not become capable of walking again were completely paralytic preoperatively.


Assuntos
Hematoma Epidural Craniano/diagnóstico , Hematoma Subdural/diagnóstico , Doenças da Medula Espinal/diagnóstico , Adulto , Idoso , Coagulantes/uso terapêutico , Terapia Combinada , Feminino , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/cirurgia , Hematoma Subdural/tratamento farmacológico , Hematoma Subdural/cirurgia , Humanos , Laminectomia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Mielografia , Prognóstico , Doenças da Medula Espinal/tratamento farmacológico , Doenças da Medula Espinal/cirurgia , Tomografia Computadorizada por Raios X
16.
Neurosurgery ; 14(6): 659-63, 1984 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-6462399

RESUMO

Dimethyl sulfoxide (DMSO) has shown promise as a drug for the treatment of intracranial hypertension. In this report, we describe our experience in six patients, two who received a bolus administration of 10% DMSO and four who received a 20% solution titrated against the intracranial pressure (ICP). Five of the patients in this series suffered from severe head injury, and one had a cortical venous thrombosis associated with pregnancy. The first two patients were treated with a rapid infusion of a 10% solution of DMSO. Initially, the ICP was satisfactorily controlled using this method. Over time, however, fluid overload, severe electrolyte disturbances, and an ultimate loss of ICP control occurred. In subsequent patients, a 20% solution titrated against the ICP was used. Although ICP control was better achieved using this method of administration, problems with fluid management and electrolytes occurred again despite a high level of vigilance. In addition, because of the solvent properties of DMSO and its propensity over time to dissolve most standard intravenous infusion systems, mechanical difficulties in its administration were encountered in all six patients. The mechanism of action of DMSO is not well understood. It differs from the barbiturates, but acts too rapidly to function solely as a diuretic. The drug is extremely complex to use, and difficulties with its administration may make its risks ultimately greater than its potential benefits. Until more laboratory data are available concerning its use and better delivery systems are developed, neurosurgeons are cautioned against treating intracranial hypertension with DMSO.


Assuntos
Dimetil Sulfóxido/uso terapêutico , Pseudotumor Cerebral/tratamento farmacológico , Adulto , Lesões Encefálicas/tratamento farmacológico , Relação Dose-Resposta a Droga , Feminino , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Subdural/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Humanos , Embolia e Trombose Intracraniana/tratamento farmacológico , Pressão Intracraniana/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Gravidez , Equilíbrio Hidroeletrolítico/efeitos dos fármacos
17.
Clin Appl Thromb Hemost ; 7(2): 166-8, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11292196

RESUMO

A 54-year-old woman who was on anticoagulant treatment with acenocoumarol for a mitral prothesis developed a cervical spinal epidural hematoma, probably triggered by coughing fits together with supratherapeutic anticoagulation. Because of the subacute evolution of the hematoma, it was not diagnosed until the patient was admitted to the hospital with profuse hemorrhages. Given the subacute nature of the hematoma, along with the favorable evolution, conservative treatment with dexamethasone was decided upon, and it was resolved with almost no sequelae. This unusual clinical entity definitely should be suspected in patients on anticoagulants who complain of severe localized neck pain, most often with radicular irradiation.


Assuntos
Anticoagulantes/efeitos adversos , Hematoma Epidural Craniano/induzido quimicamente , Acenocumarol/administração & dosagem , Acenocumarol/efeitos adversos , Administração Oral , Anticoagulantes/administração & dosagem , Vértebras Cervicais , Tosse/complicações , Dexametasona/administração & dosagem , Feminino , Hematoma Epidural Craniano/tratamento farmacológico , Hematoma Epidural Craniano/etiologia , Humanos , Pessoa de Meia-Idade
18.
Arq Neuropsiquiatr ; 61(2B): 499-502, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12894294

RESUMO

Clivus fractures are rare and severe entities, usually associated with vascular or cranial nerve lesions and frequently diagnosed postmortem. Cervical epidural haematomas can be traumatic or spontaneous, manifested in acute or chronic form, and are treated surgically in the majority of cases, although the conservative treatment also can be indicated to patients with incomplete and non-progressive deficits. The authors report the case of a female patient, 8 years old, victim of trampling in public way by a high velocity motorized vehicle, admitted in Glasgow 7, anisocoric pupils (left pupil midriatic), whose radiological investigation showed a transverse fracture of the clivus, cervical epidural haematoma and diffuse axonal injury. The patient was submitted to intracranial pressure monitorization, sedation and conservative treatment with dexamethasone, with good outcome. The authors also present a literature review.


Assuntos
Acidentes de Trânsito , Hematoma Epidural Craniano/complicações , Fraturas Cranianas/complicações , Vértebras Cervicais , Criança , Fossa Craniana Posterior/lesões , Feminino , Hematoma Epidural Craniano/diagnóstico , Hematoma Epidural Craniano/tratamento farmacológico , Humanos , Imageamento por Ressonância Magnética , Fraturas Cranianas/diagnóstico , Fraturas Cranianas/tratamento farmacológico , Tomografia Computadorizada por Raios X
19.
Kaohsiung J Med Sci ; 13(5): 328-31, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9226976

RESUMO

A 48-year-old female expressed signs of meningeal irritation after having received several lumbar acupunctures within one week for back pain. Bacterial meningitis was diagnosed from cerebrospinal fluid examinations. Magnetic resonance image (MRI) of spine at admission demonstrated a fusiform lesion with characters of subacute hematoma in the epidural space of the first and second lumbar level. She received antibiotics treatment only and recovered from her central nervous system infection completely. The epidural lesion disappeared spontaneously in the MRI follow up three weeks later. We report the diagnosis and follow-up of epidural hematoma of the lumbar spine by MRI which aided the medical physician to treat meningitis attentively.


Assuntos
Terapia por Acupuntura/efeitos adversos , Hematoma Epidural Craniano/etiologia , Meningites Bacterianas/etiologia , Feminino , Hematoma Epidural Craniano/tratamento farmacológico , Humanos , Imageamento por Ressonância Magnética , Meningites Bacterianas/tratamento farmacológico , Pessoa de Meia-Idade , Medula Espinal/patologia
20.
Neurol Neurochir Pol ; 18(2): 195-8, 1984.
Artigo em Polonês | MEDLINE | ID: mdl-6483087

RESUMO

Two patients with subacute epidural haematomas without shifted ventricular system are described in whom the diagnosis was made by computer tomography 8 and 9 days after trauma. Both patients were treated successfully checking the progress with computer tomography and using agents reducing brain oedema.


Assuntos
Concussão Encefálica/complicações , Hematoma Epidural Craniano/tratamento farmacológico , Adulto , Hematoma Epidural Craniano/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Remissão Espontânea , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA